Search hospitals > California > San Diego
UCSD Medical Center
Claim this profileSan Diego, California 92103
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Stroke
183 reported clinical trials
29 medical researchers
Summary
UCSD Medical Center is a medical facility located in San Diego, California. This center is recognized for care of Parotid Gland Cancer, Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Stroke and other specialties. UCSD Medical Center is involved with conducting 183 clinical trials across 584 conditions. There are 29 research doctors associated with this hospital, such as Lyudmila A. Bazhenova, Sandip Patel, MD, Shumei Kato, and Rana McKay, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
p16 positive
Stage III
2Cancer
Global LeaderStage IV
KRAS positive
BRAF positive
Top PIs
Lyudmila A. BazhenovaUC San Diego Moores Cancer Center4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
21 reported clinical trials
31 drugs studied
Sandip Patel, MDUC San Diego Moores Cancer Center3 years of reported clinical research
Expert in Cancer
Expert in Solid Tumors
25 reported clinical trials
45 drugs studied
Shumei KatoUC San Diego Moores Cancer Center8 years of reported clinical research
Studies Cancer
Studies Solid Tumors
19 reported clinical trials
65 drugs studied
Rana McKay, MDUC San Diego Moores Cancer Center5 years of reported clinical research
Studies Prostate Cancer
Studies Parotid Gland Cancer
14 reported clinical trials
40 drugs studied
Clinical Trials running at UCSD Medical Center
Cancer
Stroke
Alzheimer's Disease
Lung Cancer
Skin Cancer
Dementia
Parotid Gland Cancer
Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria
Iohexol-aided Carboplatin Dosing
for Cancer
This trial studies how well iohexol helps doctors calculate the dose of carboplatin for cancer patients. By measuring kidney function more accurately, doctors can improve the effectiveness and safety of carboplatin treatment. Carboplatin is a platinum-based chemotherapy drug used to treat various cancers, known for its improved toxicity profile compared to cisplatin.
Recruiting1 award Phase 17 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UCSD Medical Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.